Special warnings and special precautions for use
Coronary failure, cardiac insufficiency, tachycardiac arrhythmias:
Coronary failure must be treated prior to thyroid hormone therapy. Jodthyrox
therapy should be started with a low dose which is then gradually increased
at large time intervals.
Even mild factitial hyperthyroidism must be avoided in patients with
coronary failure, cardiac insufficiency or tachycardiac arrhythmias. Frequent
checks of thyroid hormone parameters must be made in these cases.
Diabetes mellitus:
Since thyroid hormones influence glucose absorption and insulin secretion
and sensitivity the blood glucose level must be checked regularly in the
initial phase of treatment with Jodthyrox and if any alteration is seen
the dosage of the hypoglycemic drug must be adjusted accordingly.
Pituarity and adrenocortical insufficiency:
In hypothyroidism caused by pituitary disease it is necessary to establish
whether adrenocortical insufficiency is also present. The latter would
then need to be treated before thyroid hormone treatment is commenced.
Autonomy of the thyroid:
Autonomy of the thyroid must be excluded by specific methods of diagnosis
before commencement of therapy with Jodthyrox.
Interactions
Cholestyramine:
Ingestion of cholestyramine inhibits the absorption of levothyroxine
sodium. Jodthyrox should therefore be taken 4 - 5 hours before cholestyramine
administration.
Phenytoin, salicylates, furosemide, clofibrate:
Phenytoin, salicylates, furosemide in high doses (250 mg), clofibrate
and other substances may potentiate the effect of levothyroxine.
Intravenous administration of phenytoin may produce increased concentrations
of the free thyroid hormones and in isolated cases may enhance the development
of cardiac arrhythmias.
Coumarin derivatives:
The effect of drugs which suppress the coagulation of the blood may
be potentiated by Jodthyrox. Hence at the start of treatment with Jodthyrox
coagulation parameters must be checked regularly and it may be necessary
to reduce the dose of the anticoagulant.
Antidiabetics:
Levothyroxine may alter the daily insulin requirement in diabetics.
The blood sugar level in these patients should be checked frequently at
the start of treatment with Jodthyrox and after alterations in dose. The
dose of the hypoglycemic agent should be adjusted accordingly.
Use in pregnancy and lactation
Treatment with thyroid hormones should be given consistently during
pregnancy and breast-feeding in particular. So far there have been no reports
of risk to the fetus despite extensive use during pregnancy. Even in high-dosed
levothyroxine therapy the thyroid hormone quantity secreted into breast
milk during lactation is not sufficient to cause development of hyperthyroidism
or suppression of TSH secretion in the infant.
Effects on ability to drive to to use machines
There are no indications that levothyroxine interferes with driving
a vehicle, operating machinery, or working without a firm hold..
Side effects
In patients hypersensitive to iodine ingestion of Jodthyrox can cause
fever, skin rash and reddening, pruritus and burning in the eyes, dry cough,
diarrhea or headache, in which case treatment with the preparation must
be stopped.
As a result of the increased metabolic rate due to levothyroxine tachycardia,
cardiac arrhythmias and tremor, restlessness, insomnia, excessive perspiration,
weight loss or diarrhea may occasionally occur, in particular at the start
of treatment. In the event of such reactions the daily dose should be reduced
or the drug discontinued for several days. As soon as the side effect has
disappeared treatment may be resumed with a low dose which is then cautiously
increased.
Symptoms and treatment of overdosage
After overdosage the symptoms typical of a pronounced increase in the
metabolic rate occur.
Depending on the extent of the overdose it is recommended that treatment
with the tablets is interrupted and tests carried out. Symptoms consisting
of intense beta-sympathomimetic effects such as tachycardia, anxiety, agitation,
hyperkinesia, can be reduced by beta-blockers. After extreme doses plasmapheresis
may be of help.
|